We are live on ! Find out more
RCUS icon

Arcus Biosciences

184 hedge funds and large institutions have $1.36B invested in Arcus Biosciences in 2022 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 81 increasing their positions, 54 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 15

50% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 54

20% more funds holding in top 10

Funds holding in top 10: 56 (+1)

6% more funds holding

Funds holding: 173184 (+11)

3% more capital invested

Capital invested by funds: $1.33B → $1.36B (+$35.9M)

0.4% less ownership

Funds ownership: 73.13%72.73% (-0.4%)

11% less call options, than puts

Call options by funds: $4.87M | Put options by funds: $5.46M

Holders
184
Holders Change
+11
Holders Change %
+6.36%
% of All Funds
3.17%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.1%
New
26
Increased
81
Reduced
54
Closed
15
Calls
$4.87M
Puts
$5.46M
Net Calls
-$588K
Net Calls Change
+$10.7M
Name Holding Trade Value Shares
Change
Change in
Stake
SSA
51
Schonfeld Strategic Advisors
New York
$3.42M -$925K -34,960 -21%
AQR Capital Management
52
AQR Capital Management
Connecticut
$3.14M +$1.32M +49,775 +71%
Schroder Investment Management Group
53
Schroder Investment Management Group
United Kingdom
$3.08M +$2.35M +88,849 +310%
Susquehanna International Group
54
Susquehanna International Group
Pennsylvania
$2.72M +$486K +18,374 +21%
Swiss National Bank
55
Swiss National Bank
Switzerland
$2.67M +$39.7K +1,500 +1%
ECM
56
Endurant Capital Management
California
$2.55M +$861K +32,571 +50%
Public Sector Pension Investment Board (PSP Investments)
57
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.49M +$236K +8,938 +10%
PA
58
Parallel Advisors
California
$2.22M +$132 +5 +0%
First Trust Advisors
59
First Trust Advisors
Illinois
$2.22M +$373K +14,110 +20%
BG
60
Bellevue Group
Switzerland
$2.18M -$175K -6,600 -7%
New York State Teachers Retirement System (NYSTRS)
61
New York State Teachers Retirement System (NYSTRS)
New York
$2.17M +$241K +9,100 +12%
CSS
62
Cubist Systematic Strategies
Connecticut
$1.9M -$1.16M -43,708 -38%
HS
63
HighVista Strategies
Massachusetts
$1.87M
Prudential Financial
64
Prudential Financial
New Jersey
$1.73M +$122K +4,605 +7%
PIM
65
Platinum Investment Management
Australia
$1.62M
PP
66
PDT Partners
New York
$1.53M +$817K +30,910 +112%
MPAM
67
Monarch Partners Asset Management
Massachusetts
$1.53M +$1.55M +58,430 New
Point72 Asset Management
68
Point72 Asset Management
Connecticut
$1.51M +$1.53M +57,834 New
California State Teachers Retirement System (CalSTRS)
69
California State Teachers Retirement System (CalSTRS)
California
$1.5M -$29.4K -1,112 -2%
Canada Life
70
Canada Life
Manitoba, Canada
$1.48M +$309K +11,683 +26%
Thrivent Financial for Lutherans
71
Thrivent Financial for Lutherans
Minnesota
$1.41M +$209K +7,908 +17%
Two Sigma Investments
72
Two Sigma Investments
New York
$1.3M +$1.32M +49,891 New
New York State Common Retirement Fund
73
New York State Common Retirement Fund
New York
$1.28M +$75.5K +2,853 +6%
COPPSERS
74
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.24M +$128K +4,842 +11%
YCM
75
Yousif Capital Management
Michigan
$1.15M +$100K +3,789 +9%

RCUS Hedge Fund Activity: Q3 2022 in Review

184 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Arcus Biosciences (RCUS) for Q3 2022, worth a combined $1.36B — up 2.7% from $1.33B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new RCUS positions and 15 closed out — a net gain of 11 holders — while 81 added to existing stakes and 54 trimmed.

The largest buyer was BlackRock, adding an estimated $21.3M. The largest seller was BVF Inc, cutting an estimated $32.9M.

  • 184 institutional investors held Arcus Biosciences (RCUS) as of Q3 2022, up from 173 in Q2 2022.
  • Funds reported $1.36B of Arcus Biosciences stock for Q3 2022, up 2.7% quarter-over-quarter.
  • 26 funds opened new Arcus Biosciences positions in Q3 2022 and 15 closed out, a net change of +11 holders.
  • The largest Arcus Biosciences buyer in Q3 2022 was BlackRock, an estimated $21.3M added.
  • The largest Arcus Biosciences seller in Q3 2022 was BVF Inc, an estimated $32.9M sold.

Based on aggregated 13F filings for Q3 2022.